Intervention
ITCA 650 60 mcg/day
ClinicalTrials.gov intervention label
Advertisement
Clinical trials
3 shownA Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 DiabetesNCT01455870 · 2013-05-01
COMPLETEDA Study to Evaluate ITCA 650 Compared to Glimepiride for the Treatment of Type 2 DiabetesNCT01455883 · 2013-02-01
WITHDRAWNA Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 DiabetesNCT01455909 · 2013-02-01
WITHDRAWNCommon conditions
Leading sponsors
Trial status mix
WITHDRAWN2
COMPLETED1
Phase mix
PHASE33
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.